Paraneoplastic syndromes of the spinal cord, nerve, and muscle

Muscle and Nerve

Volumn 23, Issue 12, 2000, Pages 1800-1818

  Rudnicki, Stacy A ^a   Dalmau, Josep ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Myelopathy; Myopathy; Neuropathy; Paraneoplastic

Indexed keywords

3,4 DIAMINOPYRIDINE; ALPHA INTERFERON; AZATHIOPRINE; BACLOFEN; CARBAMAZEPINE; CHLORAMBUCIL; CLONAZEPAM; CYCLOPHOSPHAMIDE; DIAZEPAM; FLUDARABINE; GUANIDINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; PHENYTOIN; PREDNISOLONE; PYRIDOSTIGMINE; RITUXIMAB;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CACHEXIA; CANCER PATIENT; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; EATON LAMBERT SYNDROME; GUILLAIN BARRE SYNDROME; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEURON DISEASE; MULTIPLE MYELOMA; MYASTHENIA GRAVIS; MYOPATHY; NEUROPATHY; NONHODGKIN LYMPHOMA; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SPINAL CORD DISEASE; WALDENSTROEM MACROGLOBULINEMIA;

ANIMALS; HUMANS; MUSCULAR DISEASES; PARANEOPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; SPINAL CORD DISEASES;

EID: 0033646640     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X     Document Type: Review

References (259)

1. Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: Complete resolution of myasthenic symptoms following antineoplastic therapy
2. Dermatomyositis associated with invasive thymoma
3. Idiopathic inflammatory myopathies
4. Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma
5. Neurocardiogenic syncope and Prinzmetal's angina associated with bronchogenic carcinoma
6. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors
7. Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-Hu antibodies: Clinicopathological study of an autopsy case
8. Dermatomyositis associated with primary intramuscular B cell lymphoma
9. Severe orthostatic hypotension in carcinoma of the pancreas
10. Cardiac abnormalities in polymyositis/dermatomyositis
11. Role of the blink reflex in the evaluation of sensory neuronopathy
12. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
13. Cancer and disorders of motor neurons
14. Thymomas: Clinicopathologic features, therapy, and prognosis
15. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease
16. Thymoma: Factors influencing prognosis
17. Carcinoid myopathy and treatment with cyproheptadine (Periactin)
18. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma
19. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease)
20. The long-term clinical outcome of myasthenia gravis in patients with thymoma
21. The stiff man and stiff man plus syndromes
22. Motor neuron disease with renal cell carcinoma and postoperative neurologic remission. A clinicopathologic report
23. Neuroendocrine lung tumors and disorders of the neuromuscular junction
24. Acute peripheral neuropathy in Hodgkin's disease. Report of a fatal case with histologic features of allergic neuritis
25. A case of Hodgkin's lymphoma producing neuromyotonia
26. Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity
27. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma
28. The distinctive clinical features of paraneoplastic sensory neuronopathy
29. Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases
30. A case of paracarcinomatous pandyautonomia
31. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction
32. Mortality and survival in myasthenia gravis: A Danish population based study
33. Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome
34. Germ cell cancer and dermatomyositis
35. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome
36. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies
37. Peripheral nervous system and spinal cord involvement in lymphoma
38. Peripheral neuropathy of sensorimotor type associated with malignant disease
39. The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses
40. Polymyositis, dermatomyositis, and inclusion-body myositis
41. Treatment of polyneuropathy in Waldenstrom's macroglobulinemia: Role of paraproteinemia and immunologic studies
42. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis
43. Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies
44. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients
45. Subacute myelopathy: An unusual paraneoplastic complication of Hodgkin's disease
46. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome
47. Myeloma neuropathy. Successful treatment of two patients and review of cases
48. Ovarian malignancy in patients with dermatomyositis and polymyositis: A retrospective analysis of fourteen cases
49. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer
50. Cross-idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenstrom's macroglobulinemia and polyneuropathy
51. Primary sensory neuropathy with muscular changes associated with carcinoma
52. Immunocytochemical binding of serum IgG from a patient with oat cell tumor and paraneoplastic motoneuron disease to normal human cortex and molecular layer of the cerebellum
53. Neurolymphomatosis: A clinicopathological syndrome re-emerges
54. Waldenstrom's macroglobulinemia: Clinical features, complications, and management
55. Peripheral neuropathy associated with Castleman's disease
56. Myasthenia gravis
57. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation
58. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis
59. Carcinomatous neuromyopathy: A case of sensory neuropathy and myopathy with onset three years and one-half years before clinical recognition of the bronchogenic carcinoma
60. Electromyography and electrical stimulation of nerves in diseases of the motor unit: Observations on a myasthenic syndrome associated with malignant tumors
61. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma
62. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients
63. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993)
64. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration
65. The polymyositis and dermatomyositis syndromes
66. Multiple paraneoplastic diseases associated with thymoma
67. Acute pandysautonomia and severe sensory deficit with poor clinical recovery. A clinical, neurophysiological and pathological case study
68. Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome
69. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer
70. A reversible cause of hypercapnic respiratory failure: Lower motor neuronopathy associated with renal cell carcinoma
71. Motor neuron syndromes in cancer patients
72. Demyelinating neuropathies triggered by melanoma immunotherapy
73. Prognostic factors and predictive signs of malignancy in adult dermatomyositis
74. Report of 8 cases of dermatomyositis: Does association of this entity and neoplasms exist?
75. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid
76. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome
77. Progressive necrotizing myelopathy associated with leukemia: Clinical, pathologic, and MRI correlation
78. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease
79. Orthostatic hypotension and vasodilatory peptides in bronchial carcinoma
80. Indolent anti-Hu-associated paraneoplastic sensory neuropathy
81. Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis
82. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis
83. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome
84. Heterogeneity of autoantibodies in stiff-man syndrome
85. Thymoma: Prognostic factors and treatment outcomes
86. Trends in the association of Lambert-Eaton myasthenic syndrome with carcinoma
87. Guillain-Barre syndrome: Diagnostic criteria, epidemiology, clinical course and prognosis
88. Paraneoplastic subacute necrotic myelopathy
89. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG
90. - channels are implicated in neuromyotonia
91. The carcinomatous neuromyopathy of oat cell lung cancer
92. Peripheral neuropathy and myopathy associated with bronchogenic carcinoma
93. Encephalomyelitis with carcinoma
94. The neuromuscular function in patients with malignant tumours. Electromyographic and histological study
95. Antibody to Jo-1 in polymyositis/dermatomyositis: Association with interstitial pulmonary disease
96. Immunological and pathological study of anti-Ri-associated encephalopathy
97. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis
98. Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease
99. Myotonia associated with small cell carcinoma of the lung
100. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma
101. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
102. A syndrome of continuous muscle-fibre activity
103. Two cases of necrotizing myelopathy associated with malignancy caused by herpes simplex virus type 2
104. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma
105. Lambert-Eaton myasthenic syndrome
106. Epidemiological features of Guillain-Barre syndrome in Sweden, 1978-93
107. Paraneoplastic vasculitis of nerve: A remote effect of cancer
108. Guillain-Barre syndrome and Hodgkin's disease. Ultrastructural study of a peripheral nerve
109. Polyneuropathy in Waldenstrom's macroglobulinemia. Deposition of M component on myelin sheaths
110. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor
111. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy
112. Peripheral neuropathies associated with monoclonal proteins: A clinical review
113. Osteosclerotic myeloma and peripheral neuropathy
114. Prevalence of monoclonal protein in peripheral neuropathy
115. Guillain-Barre syndrome: A 42-year epidemiologic and clinical study
116. Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies
117. Microvascular deposition of complement membrane attack complex in dermatomyositis
118. Severe polyneuropathy: Initial manifestation of Castleman's disease associated with POEMS syndrome
119. Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer
120. Neuropathy and IgM paraproteinemia: Differential binding of IgM M-proteins to peripheral nerve glycolipids
121. Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease
122. Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 autopsy cases
123. MR imaging in amyopathic dermatomyositis
124. Myasthenic state and lung cancer
125. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse
126. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome
127. Myotonia associated with cancer
128. Prognosis of neuropathy with monoclonal gammopathy
129. Carcinoid myopathy
130. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma
131. Malignancy in adult dermatomyositis
132. Necrotizing myelopathy complicating Hodgkin's disease
133. Paraneoplastic necrotizing myopathy: Clinical and pathological features
134. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
135. Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy
136. The effects of ageing, cachexia and neoplasms on striated muscle. Quantitative histological and histochemical observations on an autopsy material
137. Guillain-Barre syndrome and Hodgkin's disease: Three cases with immunological studies
138. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle
139. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis
140. Stiff-man syndrome updated
141. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear antoantibodies
142. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
143. Guillain-Barre syndrome in Taiwan: A clinical study of 167 patients
144. Decay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome: Effect of cooling
145. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma
146. Necrotizing myelopathy associated with visceral carcinoma
147. High incidence of malignancies in patients with dermatomyositis and polymyositis: An 11-year analysis
148. Subacute deafness in encephalomyelitis and paraneoplastic sensory neuropathy
149. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome
150. Paraneoplastic vasculitic neuropathy: Immunohistochemical studies on a biopsied nerve and post-mortem examination
151. Long-term prognosis of 69 patients with dermatomyositis or polymyositis
152. Epidermal necrosis as a predictive sign of malignancy in adult dermatomyositis
153. Role of therapeutic plasmapheresis in the acute Guillain-Barre syndrome
154. Paraneoplastic neuropathies
155. Late onset of myasthenia gravis after total resection of thymoma: Report of two cases
156. Plasma-cell dyscrasia with polyneuropathy
157. Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma
158. Progressive fluctuating muscular rigidity and spasm ('stiffman syndrome'): Report of a case and some observations in 13 other cases
159. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy
160. Electrophysiological investigations into the neurological complications of carcinoma
161. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
162. Necrotizing myelopathy associated with malignancy caused by herpes simplex virus type 2: Clinical report of two cases and literature review
163. The Crow-Fukase syndrome: A study of 102 cases in Japan
164. Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy
165. A treatment algorithm for Lambert-Eaton myasthenic syndrome
166. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review
167. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure
168. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: Evaluation by ELISA using recombinant fusion protein Jo-1 as antigen
169. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
170. Peripheral neuropathy in macroglobulinemia: Incidence and antigen-specificity of M proteins
171. The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments
172. Carcinomatous amyotrophic lateral sclerosis
173. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities
174. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
175. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: Serologic and clinical correlates
176. Paraneoplastic vasculitis of the peripheral nervous system
177. Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: Report of two cases and review of literature
178. Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome
179. Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome
180. Paraneoplastic vasculitic neuropathy: A treatable neuropathy
181. Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review
182. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group
183. Case report. Amyopathic dermatomyositis associated with transformed malignant lymphoma
184. The relationship between thymus and oncogenesis. A study of the incidence of non thymic malignancy in myasthenia gravis
185. Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer
186. Paraneoplastic myotonia
187. Neurologic complications of carcinoid
188. Carcinomatous neuromuscular syndromes. A clinical and quantitative electrophysiological study
189. Myasthenia gravis and thymoma
190. Paralytic brachial neuritis in Hodgkin's disease
191. Subacute sensory neuropathy associated with Hodgkin's disease
192. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy
193. Combined acute necrotic myelopathy (ANM) and cerebellar degeneration associated with malignant disease
194. Treatment of Lambert-Eaton syndrome with intravenous immunoglobulin
195. 2- flux in a human small cell carcinoma line
196. Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome
197. The Guillain-Barre syndrome
198. Neuropathies associated with paraproteinemia
199. Paraneoplastic motor neuron disease
200. Stiff-man syndrome in a woman with breast cancer: An uncommon central nervous system paraneoplastic syndrome
201. Cramps, spasms and muscle stiffness
202. Nervous system dysfunction in Waldenstrom's macroglobulinemia: Response to treatment
203. Subacute sensory neuropathy with remission: An association with lymphoma
204. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma
205. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies
206. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS)
207. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome
208. Subacute motor neuronopathy: A remote effect of lymphoma
209. + channels of peripheral nerves
210. Dermatomyositis and malignant melanoma
211. A study of the effects upon the motor unit by remote malignancy
212. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study
213. Paraneoplastic stiff limb syndrome
214. Antitumor activity of thalidomide in refractory multiple myeloma
215. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)
216. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study
217. Resolution of musculoskeletal symptoms in the carcinoid syndrome after treatment with the somatostatin analog octreotide
218. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome
219. Guillain-Barre syndrome in the elderly. A retrospective comparative study
220. Association of subacute motor neuronopathy with thymoma
221. Eaton-Lambert myasthenic syndrome: Long-term treatment of three patients with prednisone
222. Carcinoid myopathy: Serotonin-induced muscle weakness in man?
223. Some features of the neuromuscular complications of pulmonary carcinoma
224. Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients
225. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome
226. Biology of cachexia
227. Myasthenia gravis as a paraneoplastic syndrome associated with renal cell carcinoma
228. Peripheral neuropathy and myopathy associated with carcinoma of the lung
229. Subclinical autonomic dysfunction in patients with Hodgkin's disease and non-Hodgkin's lymphoma
230. Non-Hodgkin malignant lymphomas and peripheral neuropathies - 13 Cases
231. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome
232. Acute dysautonomia associated with Hodgkin's disease
233. Anti-MAG and anti-SGPG antibodies in neuropathy
234. Muscle hypertrophy and a syndrome of continuous motor unit activity in prednisone-responsive Guillain-Barre polyneuropathy
235. Paraneoplastic encephalomyelitis and subacute dysautonomia due to an occult atypical carcinoid tumour of the lung
236. Motor neuron disease: A paraneoplastic process associated with anti-Hu antibody and small-cell lung carcinoma
237. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes
238. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays
239. Nerve and muscle microvasculitis in peripheral neuropathy: A remote effect of cancer?
240. Chronic relapsing neuropathy associated with Castleman's disease (angiofollicular lymph node hyperplasia)
241. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients
242. Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia: An ultrastructural and immunopathologic study
243. P/Q-type voltage gated calcium channel antibodies in patients with paraneoplastic disorders of the central nervous system
244. Paraneoplastic myasthenia gravis: Detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor
245. Neuromyotonia and bronchial carcinoma
246. The neuropathy of multiple myeloma. An electrophysiological and histological study
247. Neuromyotonia: An unusual presentation of intrathoracic malignancy
248. Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study
249. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma
250. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy
251. Progressive encephalomyelitis with rigidity
252. Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2
253. Successful treatment of IgM paraproteinaemic neuropathy with fludarabine
254. Primary lateral sclerosis. A clinical diagnosis reemerges
255. Anti-Hu-associated peripheral nerve and muscle microvasculitis
256. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis
257. Motor neuron disease and amyotrophic lateral sclerosis: Relation of high CSF protein content to paraproteinemia and clinical syndromes
258. Paraneoplastic encephalomyeloneuritis obscured by coma
259. Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemia